$24.75
-0.34%Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.
CON • NYSE
| Concentra Group Holdings Parent, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||
172.8M | 171.9M | 184.7M | 172.2M | 216M | |
0.0 | 67.2M | 73.1M | 73.7M | 82.2M | |
0.0 | -2.4M | -6.3M | -8.6M | -1.3M | |
0.0 | 2.3M | 651K | 2.1M | 2.1M | |
98.6M | 5.5M | 857K | 1M | -1.1M | |
(45.9M) | (55.8M) | (60.6M) | (42.2M) | (78.4M) | |
8M | 30.2M | -18.7M | 33.9M | -7.3M | |
279.4M | 274.7M | 234.3M | 274.3M | 290.6M | |
INVESTING ACTIVITIES | |||||
(0.0) | -64.3M | -69.3M | -46M | -46.8M | |
(0.0) | -7M | -6M | -11.8M | -20.1M | |
-414.9M | 27K | 36K | 38K | 5.1M | |
-414.9M | -71.3M | -75.3M | -57.8M | -61.8M | |
FINANCING ACTIVITIES | |||||
-22.4M | 495.8M | -2M | -29.1M | 0.0 | |
90.4M | 1,000M | -161.7M | -184.7M | -326.9M | |
-32.1M | -1.5B | -6.1M | (0.0) | (0.0) | |
-22.4M | -15.4M | -5.3M | -29.1M | (0.0) | |
-3.8M | -3.6M | 4.5M | 3.9M | -15.7M | |
32.1M | -51.5M | -165.3M | -209.9M | -342.6M | |
CASH FLOW SUMMARY | |||||
-103.4M | 151.9M | -6.3M | 6.7M | -113.7M | |
183.3M | 31.4M | 37.7M | 30.9M | 144.7M | |
79.9M | 183.3M | 31.4M | 37.7M | 30.9M | |
197.1M | 210.4M | 165M | 228.4M | 243.9M |
CON - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 14, 2026 | April 14, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 17, 2026 | April 30, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 25, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 28, 2026 | January 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 10, 2025 | November 04, 2025 | 2025 |
Continue your CON research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.